APVO icon

Aptevo Therapeutics
APVO

Overview Fund Trends Analyst Outlook Journalist POV

12 hedge funds and large institutions have $14.8M invested in Aptevo Therapeutics in 2019 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 1 increasing their positions, reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding: →

more ownership

Funds ownership: →

Holders
12
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$675K
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$3.5M
2
+$1.98M
3
+$900K
4
CH
CVI Holdings
Delaware
+$703K
5
Alyeska Investment Group
Alyeska Investment Group
Illinois
+$631K

Top Sellers

1
-$587K
2
-$419K
3
-$370K
4
SIM
Spark Investment Management
New York
-$172K
5
Geode Capital Management
Geode Capital Management
Massachusetts
-$145K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$33K
27
$24K
28
$23K
29
$19K
30
$15K
31
$15K
32
$14K
33
$14K
34
$11K
35
$10K
36
$10K
37
$10K
38
$7K
39
$5K
40
$2K
41
$1K
42
$1K
43
$90
44
$6
45
$5
46
–
47
–
48
–
49
–
50
–
1
2
3